期刊文献+

“LTB-S”分类法与耐多药肺结核手术适应证探讨 被引量:21

The value of LTB-S classification in surgical indication for multidrug-resistant tuberculosis
下载PDF
导出
摘要 目的探讨"LTB-S"分类法在耐多药肺结核手术适应证方面的价值,以减少肺结核患者的手术并发症和医疗费用。方法以中华医学会结核病学分会的《临床技术操作规范结核病分册》为依据,建立一套简单实用的"LTB-S"最佳手术时机判断系统,将耐多药肺结核外科手术患者分为Ⅰ类(绝对手术适应证)、Ⅱ类(相对手术适应证)、Ⅲ类(无手术适应证)。同时选择现有的已手术的27例肺结核手术患者进行验证分析。结果27例患者中,Ⅰ类8例,Ⅱ类17例,Ⅲ类2例,符合"LTB-S"最佳手术时机判断原则的Ⅰ类患者无并发症发生,Ⅱ类和Ⅲ类患者各出现2例手术并发症,其中Ⅲ类患者手术并发症发生率100%(2/2)。随访4个月至12年,2例Ⅲ类患者未治愈,其余患者均治愈。结论LTB-S判断系统有助于耐多药肺结核患者最佳手术适应症的判断,具有实用的临床价值,适宜在临床中推广应用。 Objective To explore the value of LTB-S classification in surgical indication for multidrug-resis- tant tuberculosis, looking for a judging system of the optimal operation time in patients with multidrug-resistant tu- berculosis to reduce the complications and medical costs. Methods We set up a simple practical LTB-S judgment system for surgery of multidrug-resistant tuberculosis based on《 Clinical technology operating specifications(tubercu- losis section) 》 written by Chinese Medical Association Tuberculosis Branch. Patients were divided into class Ⅰ , Ⅲ, which definited absolute sugery indication, relative indication and contraindication, respectively. Twenty-seven cases with pulmonary tuberculosis who has been underwent surgery were randomly chosen for this confirmatory analysis. Results Of 27 patients, 8 patients belonged to class Ⅰ , 17 class Ⅱ , and 2 class In in those who com- plied with the LTB-S class Ⅰ had no complications, the patients which complied with the LTB-S class Ⅱ and Ⅲ have much more complications which incidence were 2 patients (100G in class Ⅲ ), respectively. Conclusion LTB-S judging system is helpful for the judgment of operative indications for multidrug-resistant tuberculosis, it is very practical on clinical and suitable for TB physicians learning and understanding.
出处 《中国防痨杂志》 CAS 2012年第4期245-247,共3页 Chinese Journal of Antituberculosis
关键词 结核 肺/外科学 抗药性 多种 细菌 外科手术 选择性 Tuberculosis,pulmonary/surgery Drug resistance,multiple, bacterial Surgical procedures,elective
  • 相关文献

参考文献5

  • 1杜建,徐彩红,李琦,姜晓颖,马艳,高静韬,端木宏谨,傅瑜,李亮.不同类型治疗方案治疗耐多药结核病效果文献分析[J].中国防痨杂志,2010,32(8):421-426. 被引量:34
  • 2中华医学会.临床技术操作规范结核病分册[M]北京:人民军医出版社,2004.
  • 3肖和平.耐药结核病化学治疗指南(2010年)[M]北京:人民军医出版社,201.
  • 4World Health Organization;中国疾病预防控制中心结核病防治临床中心;世界卫生组织结核病研究培训合作中心;中华医学会结核病学分会.耐药结核病规划管理指南(2008紧急修订版)[M]北京:中国疾病预防控制中心结核病防治临床中心,200867.
  • 5赵兴吉,方祥和,杨大业,朱彦,余欣.肺结核的外科治疗(附345例临床分析)[J].四川医学,1994,15(5):260-262. 被引量:10

二级参考文献30

  • 1Burgos M, Gonzalez LC, Paz EA, Gournis E, Kawamura LM, Schecter G, Hopewell PC, Daley CL. Treatment of Muhidrug- Resistant Tuberculosis in San Francisco: an Outpatient-Based Approach[J]. Clin Infect Dis, 2005, 40(7):968-975.
  • 2Chan ED, Laurel V, Strand MJ, Chan JF, Huynh ML, Ooble M, Iseman MD. Treatment and Outcome Analysis of 205 Patients with Multidrug-Resistant Tubereulosis[J]. Am J Respir Crit Care Med, 2004,169(10):103-9.
  • 3Palmero DJ, Ambroggi M, Brea A, De Lueas M, Fulgenzi A, Martinez D, Mosea C, Musella R, Natiello M, Gonzalez C, Abbate E. Treatment and Follow-up of HIV-Negative Multi drug-Resistant Tuberculosis Patients in an Infectious Diseases Reference Hospital, Buenos Aires, Argentina[J]. Int J Tuberc Lung Dis, 2004, 8(6):778-784.
  • 4Holtz TH, Sternberg M, Kammerer S, Laserson KF, Riekstina V, Zarovska E, Skripconoka V, Wells CD, Leimane V. Time to Sputum Culture Conversion in Multidrug-Resistant Tuberculosis: Predictors and Relationship to Treatment Outcome[J]. Ann Intern Med, 2006, 144(9):650-659.
  • 5Tahaoglu K, Torun T, Sevim T, Atac G, Kir A, Karasulu L, Ozmen I, Kapakli N. The Treatment of Multidrug-Resistant Tuberculosis in Turkey[J]. N Engl J Med. 2001, 345(3):170 -174.
  • 6Park SK, Lee WC, Lee DH, Mitnick CD, Han L, Seung KJ. Self-administered, Standardized Regimens for Multidrug-Resistant Tuberculosis in South Korea[J]. Int J Tuberc Lung Dis, 2004, 8(3):361-368.
  • 7Van Deun A, Salim MA, Das AP, Bastian I, Portaels F. Resuits of a Standardised Regimen for Multidrug-Resistant Tuberculosis in Bangladesh[J]. Int J Tuberc Lung Dis, 2004, 8 (5) :560-567.
  • 8Yew WW, Chan CK, Chau CH, Tam CM, Leung CC, Wong PC, Lee J. Outcomes of Patients With Multidrug-Resistant Pulmonary Tuberculosis Treated With Ofloxacin/Levofloxacin- Containing Regimens[J]. Chest, 2000, 117(3) :744-751.
  • 9Olle-Goig JE, Sandy R. Outcomes of Individualised Treatment for Multidrug-Resistant Tuberculosis before DOTS-plus[J]. Int J Tuberc Lung Dis, 2005 Jul;9(7):765-770.
  • 10Senaratne WV. Outcome of Treatment of Multidrug Resistant Tuberculosis[J]. Ceylon MedJ. 2004, 49(3):86-87.

共引文献42

同被引文献229

引证文献21

二级引证文献156

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部